Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02441517
Title A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel Treatment in Patients Who Have Previously Received Enzalutamide
Recruitment Terminated
Gender male
Phase FDA approved
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Age Groups: adult
Covered Countries USA


No variant requirements are available.